臨床檢驗市場，規模，佔有率，趨勢，產業分析報告:各類型，各最終用途，各地區 - 2025年～2034年的市場預測

根據 Polaris Market Research 的最新研究，預計到 2034 年，臨床檢測市場規模將達到 2,871.2 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

臨床檢測是指為評估健康狀況、檢測異常並指導醫療決策而進行的系統的診斷評估。自動化和數位技術在實驗室運作中的日益融合，提高了效率、準確性和周轉時間，從而推動了市場擴張。自動化分析儀、人工智慧驅動的數據解讀和先進的資訊系統簡化了工作流程，減少了人為錯誤，並提高了診斷的可靠性。這些技術變革改善了患者的治療效果，並滿足了現代醫療保健系統對高通量檢測日益增長的需求。

臨床檢測市場受個人化醫療日益增長的關注所驅動，個人化醫療需要根據患者個體情況量身定制的先進診斷方法。臨床檢測在識別生物標記、遺傳易感性和治療反應方面發揮核心作用，從而支持標靶治療。精準醫療的日益普及推動了對常規診斷之外的專業化和廣泛檢測的需求。這種朝向以患者為中心的解決方案的轉變，強化了檢測服務對於提供有效和個人化醫療服務的策略性重要性。

臨床檢驗市場報告重點

按類型劃分，糖化血紅蛋白 (HbA1c) 檢測部門市場將在 2024 年佔總收入的 16.42%，這得益於糖尿病患病率的上升以及對長期血糖監測日益增長的關注。

按最終用途劃分，預計初級臨床部門市場的複合年增長率將達到 8.6%，這得益於對即時檢測的需求和診斷途徑的改善。

受先進基礎設施和新診斷技術應用的推動，到2024年，北美將以40.47%的佔有率佔全球市場主導地位。

受都市化和醫療保健支出成長的推動，預計亞太市場在2025年至2034年間的複合年增長率將達到9.7%。

全球主要市場參與者包括雅培實驗室、奧雅納公司實驗室、中生北控生物科技股份有限公司、查爾斯河實驗室、費森尤斯醫療、Genoptix公司、Healthscope有限公司、美國實驗室控股公司（LabCorp）、默克公司、NeoGenomics實驗室、OPKO Health公司、凱傑公司、Quest Diagnostics公司、西門子醫療股份公司、Snos.Snos.Snos.S.A.S.A.Snos.S.

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 臨床檢驗市場洞察

• 臨床檢驗- 產業概要
• 臨床檢驗市場動態
  • 促進因素和機會
    • 臨床試驗的快速創新
    • 人口老化與目標疾病盛行率上升
  • 阻礙與課題
    • 高昂的程序成本和模糊的監管框架
• 波特五力模型
  • 供應商議價能力（中）
  • 新進入者的威脅（中）
  • 買方議價能力（高）
  • 替代品的威脅（低）
  • 現有企業之間的競爭（高）
• 政治、經濟、社會和技術 (PEST) 分析
• COVID-19 影響分析與產業趨勢

第5章 臨床檢驗市場評估:各類型

• 簡介
• 全血球計數
• HGB/HCT
• 基礎代謝面板
• BUN血肌酐檢驗
• 電解質檢驗
• HbA1c檢驗
• 總括的代謝面板
• 肝臟面板
• 腎臟面板
• 脂質面板

第6章 臨床檢驗市場評估:各最終用途

• 簡介
• 中央研究所
• 基層診所

第7章 臨床檢驗市場評估:各地區

• 簡介
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
  • 奧地利
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 印尼
  • 馬來西亞
  • 韓國
• 南美
  • 巴西
  • 墨西哥
• 中東·非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第8章 企業簡介

• Abbott Laboratories
• ARUP Laboratories
• OPKO Health, Inc.
• NeoGenomics Laboratories, Inc.
• Genoptix, Inc.
• Healthscope Ltd.
• Laboratory Corporation of America Holdings(LabCorp)
• Fresenius Medical Care
• Quest Diagnostics
• Sonic Healthcare
• QIAGEN
• Siemens Healthineers AG
• Merck KgaA
• Tulip Diagnostics(P)Ltd.
• Biosino Bio-Technology and Science Inc.
• Charles River Laboratories

The clinical laboratory tests market size is expected to reach USD 287.12 billion by 2034, according to a new study by Polaris Market Research. The report "Clinical Laboratory Tests Market Share, Size, Trends, Industry Analysis Report: By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Clinical laboratory tests are defined as systematic diagnostic evaluations conducted to assess health status, detect abnormalities, and guide medical decisions. The rising integration of automation and digital technologies in laboratory operations, which enhances efficiency, accuracy, and turnaround times, drives the market expansion. Automated analyzers, AI-driven data interpretation, and advanced informatics systems are streamlining workflows and reducing human errors, making diagnostics more reliable. This technological transformation improves patient outcomes and also addresses the growing demand for high-throughput testing in modern healthcare systems.

The clinical laboratory tests market is driven by the rising focus on personalized medicine, which requires advanced diagnostics tailored to individual patient profiles. Laboratory testing has a central role in identifying biomarkers, genetic predispositions, and treatment responses, thereby supporting targeted therapies. The growing adoption of precision healthcare is fueling demand for specialized and vast tests that go beyond routine diagnostics. This shift towards patient-centric solutions is reinforcing the strategic importance of laboratory services in delivering effective, customized medical care.

Clinical Laboratory Tests Market Report Highlights

In terms of type, the HbA1c tests segment held a 16.42% revenue share in 2024, driven by rising diabetes rates and a growing focus on long-term glucose monitoring.

Based on end use, the primary clinics segment is projected to grow at a robust 8.6% CAGR, driven by demand for point-of-care testing and better diagnostic access.

North America held a dominant 40.47% global market share in 2024, due to its advanced infrastructure and adoption of new diagnostic technologies.

The Asia Pacific market is forecasted to grow at a 9.7% CAGR from 2025 to 2034, driven by urbanization and increasing healthcare spending.

A few global key market players include Abbott Laboratories; ARUP Laboratories; Biosino Bio-Technology and Science Inc.; Charles River Laboratories; Fresenius Medical Care; Genoptix, Inc.; Healthscope Ltd.; Laboratory Corporation of America Holdings (LabCorp); Merck KgaA; NeoGenomics Laboratories, Inc.; OPKO Health, Inc.; QIAGEN; Quest Diagnostics; Siemens Healthineers AG; Sonic Healthcare; and Tulip Diagnostics (P) Ltd.

Polaris Market Research has segmented the market report on the basis of type, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Complete Blood Count

HGB/HCT

Basic Metabolic Panel

BUN Creatinine Tests

Electrolytes Testing

HbA1c Tests

Comprehensive Metabolic Panel

Liver Panel

Renal Panel

Lipid Panel

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Central Laboratories

Primary Clinics

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

Chapter 1. Introduction

• 1.1 Report Description
  • 1.1.1 Objectives of the Study
  • 1.1.2 Market Scope
  • 1.1.3 Assumptions
• 1.2 Stakeholders

Chapter 2. Executive Summary

Chapter 3. Research Methodology

• 3.1 Overview
  • 3.1.1 Data Mining
• 3.2 Data Sources
  • 3.2.1 Primary Sources
  • 3.2.2 Secondary Sources

Chapter 4. Clinical Laboratory Tests Market Insights

• 4.1 Clinical Laboratory Tests - Industry snapshot
• 4.1 Clinical Laboratory Tests Market Dynamics
  • 4.1.1 Drivers and Opportunities
    • 4.1.1.1 Rapid innovations in the Clinical Laboratory Tests
    • 4.1.1.2 Rising Geriatric Population and Rising Prevalence Of Target Diseases
  • 4.1.2 Restraints and Challenges
    • 4.1.2.1 High Procedure Costs and Presence of Ambiguous Regulatory Framework
• 4.2 Clinical Laboratory Tests Market - Porter's Five Forces
  • 4.2.1 Bargaining Power of Suppliers (Moderate)
  • 4.2.2 Threats of New Entrants: (Moderate)
  • 4.2.3 Bargaining Power of Buyers (High)
  • 4.2.4 Threat of Substitute (Low)
  • 4.2.5 Rivalry among existing firms (High)
• 4.3 Political, Economic, Social, and Technological (PEST) Analysis
• 4.4 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Clinical Laboratory Tests Market Assessment by Type

• 5.1 Introduction
• 5.2 Complete Blood Count
• 5.3 HGB/HCT
• 5.4 Basic Metabolic Panel
• 5.5 BUN Creatinine Tests
• 5.6 Electrolytes Testing
• 5.7 HbA1c Tests
• 5.8 Comprehensive Metabolic Panel
• 5.9 Liver Panel
• 5.10 Renal Panel
• 5.11 Lipid Panel

Chapter 6. Clinical Laboratory Tests Market Assessment by End-Use

• 6.1 Introduction
• 6.2 Central Laboratories
• 6.3 Primary Clinics

Chapter 7. Clinical Laboratory Tests Market Assessment by Region

• 7.1 Introduction
• 7.2 Clinical Laboratory Tests Market - North America
  • 7.2.1 Clinical Laboratory Tests Market - U.S.
  • 7.2.2 Clinical Laboratory Tests Market - Canada
• 7.3 Clinical Laboratory Tests Market - Europe
  • 7.3.1 Clinical Laboratory Tests Market - Germany
  • 7.3.2 Clinical Laboratory Tests Market - UK
  • 7.3.3 Clinical Laboratory Tests Market - France
  • 7.3.4 Clinical Laboratory Tests Market - Italy
  • 7.3.5 Clinical Laboratory Tests Market - Spain
  • 7.3.6 Clinical Laboratory Tests Market - Netherlands
  • 7.3.7 Clinical Laboratory Tests Market - Austria
• 7.4 Clinical Laboratory Tests Market - Asia Pacific
  • 7.4.1 Clinical Laboratory Tests Market - China
  • 7.4.2 Clinical Laboratory Tests Market - India
  • 7.4.3 Clinical Laboratory Tests Market - Japan
  • 7.4.4 Clinical Laboratory Tests Market - Indonesia
  • 7.4.5 Clinical Laboratory Tests Market - Malaysia
  • 7.4.6 Clinical Laboratory Tests Market - South Korea
• 7.5 Clinical Laboratory Tests Market - Latin America
  • 7.5.1 Clinical Laboratory Tests Market - Brazil
  • 7.5.2 Clinical Laboratory Tests Market - Mexico
• 7.6 Clinical Laboratory Tests Market - Middle East & Africa
  • 7.6.1 Clinical Laboratory Tests Market - Saudi Arabia
  • 7.6.2 Clinical Laboratory Tests Market - UAE

Chapter 8. Company Profiles

• 8.1 Abbott Laboratories
  • 8.1.1 Business Overview
  • 8.1.2 Financial Snapshot
  • 8.1.3 Products and Services
  • 8.1.4 Recent Developments
• 8.2 ARUP Laboratories
  • 8.2.1 Business Overview
  • 8.2.2 Products and Services
  • 8.2.3 Recent Developments
• 8.3 OPKO Health, Inc.
  • 8.3.1 Business Overview
  • 8.3.2 Financial Snapshot
  • 8.3.3 Products and Services
  • 8.3.4 Recent Developments
• 8.4 NeoGenomics Laboratories, Inc.
  • 8.4.1 Business Overview
  • 8.4.2 Financial Snapshot
  • 8.4.3 Products and Services
  • 8.4.4 Recent Developments
• 8.5 Genoptix, Inc.
  • 8.5.1 Business Overview
  • 8.5.2 Products and Services
• 8.6 Healthscope Ltd.
  • 8.6.1 Business Overview
  • 8.6.2 Products and Services
• 8.7 Laboratory Corporation of America Holdings (LabCorp)
  • 8.7.1 Business Overview
  • 8.7.2 Financial Snapshot
  • 8.7.3 Products and Services
  • 8.7.4 Recent Developments
• 8.8 Fresenius Medical Care
  • 8.8.1 Business Overview
  • 8.8.2 Financial Snapshot
  • 8.8.3 Products and Services
  • 8.8.4 Recent Developments
• 8.9 Quest Diagnostics
  • 8.9.1 Business Overview
  • 8.9.2 Financial Snapshot
  • 8.9.3 Products and Services
  • 8.9.4 Recent Developments
• 8.10 Sonic Healthcare
  • 8.10.1 Business Overview
  • 8.10.2 Financial Snapshot
  • 8.10.3 Products and Services
• 8.11 QIAGEN
  • 8.11.1 Business Overview
  • 8.11.2 Financial Snapshot
  • 8.11.3 Products and Services
• 8.12 Siemens Healthineers AG
  • 8.12.1 Business Overview
  • 8.12.2 Financial Snapshot
  • 8.12.3 Products and Services
• 8.13 Merck KgaA
  • 8.13.1 Business Overview
  • 8.13.2 Financial Snapshot
  • 8.13.3 Products and Services
• 8.14 Tulip Diagnostics (P) Ltd.
  • 8.14.1 Business Overview
  • 8.14.2 Products and Services
  • 8.14.3 Recent Developments
• 8.15 Biosino Bio-Technology and Science Inc.
  • 8.15.1 Business Overview
  • 8.15.2 Financial Snapshot
  • 8.15.3 Products and Services
• 8.16 Charles River Laboratories
  • 8.16.1 Business Overview
  • 8.16.2 Financial Snapshot
  • 8.16.3 Products and Services

List of Tables

• Table 1 North America diabetes prevalence (national prevalence %), 2024 & 2034
• Table 2 Europe diabetes prevalence (national prevalence %), 2024 & 2034
• Table 3 Asia Pacific diabetes prevalence (national prevalence %), 2024 & 2034
• Table 4 Latin America Diabetes Prevalence (national prevalence %), 2024 & 2034
• Table 5 MEA and Africa diabetes prevalence (national prevalence %), 2024 & 2034
• Table 6 CIS diabetes prevalence (national prevalence %), 2024 & 2034
• Table 7 Global Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 1 Global Clinical Laboratory Tests Market, by Complete Blood Count, 2021 - 2034 (USD Billion)
• Table 2 Global Clinical Laboratory Tests Market, by HGB/HCT, 2021 - 2034 (USD Billion)
• Table 3 Global Clinical Laboratory Tests Market, by Basic Metabolic Panel, 2021 - 2034 (USD Billion)
• Table 4 Global Clinical Laboratory Tests Market, by BUN Creatinine Tests, 2021 - 2034 (USD Billion)
• Table 5 Global Clinical Laboratory Tests Market, by Electrolytes Testing, 2021 - 2034 (USD Billion)
• Table 6 Global Clinical Laboratory Tests Market, by HbA1c Tests, 2021 - 2034 (USD Billion)
• Table 7 Global Clinical Laboratory Tests Market, by Comprehensive Metabolic Panel, 2021 - 2034 (USD Billion)
• Table 8 Global Clinical Laboratory Tests Market, by Liver Panel, 2021 - 2034 (USD Billion)
• Table 9 Global Clinical Laboratory Tests Market, by Renal Panel, 2021 - 2034 (USD Billion)
• Table 10 Global Clinical Laboratory Tests Market, by Lipid Panel, 2021 - 2034 (USD Billion)
• Table 11 Global Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 12 Global Clinical Laboratory Tests Market, by Central Laboratories, 2021 - 2034 (USD Billion)
• Table 13 Global Clinical Laboratory Tests Market, by Primary Clinics, 2021 - 2034 (USD Billion)
• Table 14 Clinical Laboratory Tests Market Assessment, By Geography, 2021 - 2034 (USD Billion)
• Table 15 North America Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 16 North America Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 17 U.S. Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 18 U.S. Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 19 Canada Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 20 Canada Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 21 Europe Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 22 Europe Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 23 Germany Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 24 Germany Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 25 UK Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 26 UK Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 27 France Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 28 France Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 29 Italy Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 30 Italy Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 31 Spain Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 32 Spain Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 33 Netherlands Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 34 Netherlands Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 35 Austria Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 36 Austria Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 37 Asia Pacific Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 38 Asia Pacific Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 39 China Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 40 China Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 41 India Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 42 India Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 43 Japan Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 44 Japan Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 45 Indonesia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 46 Indonesia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 47 Malaysia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 48 Malaysia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 49 South Korea Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 50 South Korea Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 51 Latin America Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 52 Latin America Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 53 Brazil Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 54 Brazil Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 55 Mexico Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 56 Mexico Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 57 Middle East & Africa Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 58 Middle East & Africa Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 59 Saudi Arabia Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 60 Saudi Arabia Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)
• Table 61 UAE Clinical Laboratory Tests Market, By Type, 2021 - 2034 (USD Billion)
• Table 62 UAE Clinical Laboratory Tests Market, By End-Use, 2021 - 2034 (USD Billion)

List of Figures

• Figure 1. Executive Summary
• Figure 2. Research Methodology: Top Down & Bottom-Up Approach
• Figure 3. Market by Geography, 2017 - 2028 (USD Billion)
• Figure 4. Global percentage of population, by age group, 2000 and 2050
• Figure 5. Population over the age of 65 years, by region, 2010 and 2050
• Figure 6. Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
• Figure 7. Current and projected prevalence of diabetes, by geography, 2024 & 2034 (% increase)
• Figure 8. Porter's Five Forces
• Figure 9. Political, Economic, Social, and Technological (PEST) Analysis
• Figure 10. Market by Type
• Figure 11. Global Clinical Laboratory Tests Market, By Type, 2025 & 2034 (USD Billion)
• Figure 12. Market by End-Use
• Figure 13. Global Clinical Laboratory Tests Market, By End-Use, 2025 & 2034 (USD Billion)
• Figure 14. Clinical Laboratory Tests Market Assessment, By Geography, 2025 & 2034 (USD Billion)